These compounds yielded significant improvements in potency, selectivity, and pharmacokinetic properties while maintaining key interactions with JNK3
48-Week Cost Estimate for Canadians Pharmaceutical Retatrutide (when approved): Weeks 1-4 (2mg): ~$400-500 monthly = $400-500 Weeks 5-8 (4mg): ~$600-750 monthly = $600-750 Weeks 9-48 (8-12mg): ~$1,200-1,500 monthly x 10 months = $12,000-15,000 Total 48-week cost: $13,000-16,250 CAD before insurance Costs decrease substantially with insurance coverage or using research suppliers
After that, many patients shift to monthly doses for maintenance
Mean total Sharp score (mTSS) progression for the placebo group in this trial was small relative to what has been seen in RA (approximately 1 unit over 48 weeks), but this progression was clearly greater than in the etanercept group, where there was no mean total Sharp progression at both 24 and 48 weeks (Figure 7-5)
The transmembrane protease-activated receptor 2 (PAR-2), which is expressed on keratinocytes and has an important role in the formation of melanocyte dendrites and the phagocytosis of melanosomes by keratinocytes [129, 130], could also be specifically blocked by compounds to decrease epidermal pigmentation [131]
